Work

RWD169 Resource Utilization of Different Remission and Relapse Profiles in Chronic Urticaria—Results From Predict-CSU Real-World Study in the United States

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.09.2886

Authors: M.M. Balp, I. Pivneva, A. Danyliv, K. Chen, T. Cornwall, J. Signorovitch, D. Patil, R. Kohli, T. Severin, W. Soong, A. Marsland

Institutions: Novartis (Switzerland), Analysis Group (United States), Novartis (United States), Novartis (India), University of Manchester

Language: English

Topic: Urticaria and Related Conditions

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4390129384

Cites:

Cited by:

Related to: 10